3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Lymphoid
1
Breast
1
Conditions
Breast Neoplasms
29
Neoplasms
28
Depression
25
Fatigue
18
Prostatic Neoplasms
12
Anxiety Disorders
12
Pain
8
Lung Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Colorectal Neoplasms
6
Colonic Neoplasms
6
Vomiting
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Nausea
5
Multiple Myeloma
5
Uterine Cervical Neoplasms
4
Lymphoma, Follicular
4
Lymphoma
4
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myeloid, Acute
4
Head and Neck Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Burkitt Lymphoma
4
Testicular Neoplasms
3
Neuroblastoma
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, B-Cell, Marginal Zone
3
Interventions
ferumoxtran-10
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Therapeutics
1
Radiotherapy
1
Radiation Dose Hypofractionation
1
Pregnancy Tests
1
Manual Lymphatic Drainage
1
Magnetic Resonance Spectroscopy
1
Imagery, Psychotherapy
1
Human Papillomavirus DNA Tests
1
Geriatric Assessment
1
Exercise
1
Educational Status
1
Diffusion
1
Continuous Positive Airway Pressure
1
Colposcopy
1
Chemical Fractionation
1
Biopsy, Needle
1
Biopsy
1
Acetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Urogenital Neoplasms
×
Therapeutics
×
Clear all
NCT05509751
2026-04-28
SOAR
University of Toronto
Phase NA
Active not recruiting
60 enrolled